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ABSTRACT
Purpose: Healthcare workers have a main role in
detection, assessment and spontaneous reporting of
adverse drug reactions (ADRs), and improvement of
their related knowledge, attitude and perception is
essential. The goal of this study was evaluation of
clinical pharmacists’ interventions in improvement of
knowledge, attitude and perception of healthcare
workers about ADRs in a teaching referral hospital,
Tehran, Iran.
Method: Changes in knowledge, attitude and
perception of healthcare workers of Imam teaching
hospital about ADRs were evaluated before and after
clinical pharmacists’ interventions including
workshops, meetings and presentations.
Results: From the 100 participated subjects, 82 of
them completed the study. 51% of the health workers
have been aware of the Iranian Pharmacovigilance
Center at the ministry of health before intervention and
after that all the participants knew this centre. About
awareness and detection of ADRs in patients, 69
(84.1%) healthcare workers recognised at least one,
and following interventions, it was improved to 73
(89%). Only seven (8.5%) subjects have reported
ADRs in before intervention phase that were increased
signiﬁcantly to 18 (22%) after intervention.
Conclusion: Clinical pharmacists’ interventions were
successful in improvement of healthcare workers’
knowledge, attitude and perception about ADRs and
spontaneous reporting in our hospital.
INTRODUCTION
Adverse drug reactions (ADRs) are a major
cause of morbidity and mortality around the
world and have high economic burden on
healthcare systems.
1e3 Pharmacovigilance
studies are more important for evaluating
medication safety following drugs
marketing.
4 Healthcare workers, especially
medical practitioners, are the principal
contributors of ADR reports.
5 Healthcare
professionals’ knowledge, attitudes and
perceptions about ADR have central role in
improvement of patients’ safety.
156There
are some concerns about ADR spontaneous
reporting by healthcare workers, including
ADR importance, do not know how to report
and ﬁll the yellow cards, doubt about adverse
effect and suspicious drug, lack of time, fear
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Open Access Researchof legal problems, avoiding paper works and unavailable
yellow card.
15 e7 WHO standards show that the best
spontaneous reporting rate is over 200 reports per
1000000 populations per year. Consequently, in Iran
with a population of over 70 million, it is expected to
have at least 14000 reports per year that unfortunately
only 4967 reports per year were sent to the Iranian
Pharmacovigilance Center (IPC).
6
Continuous education of healthcare workers about
pharmacovigilance by oral presentations, verbal
reminders, providing ADR newsletters by email, mailing
and direct distribution for hospital staff, advertisement,
increased accessibility of yellow cards, attending of
pharmacist in the medical wards and involving actively in
education and training of healthcare workers especially
nurses and physicians were proposed for improvement
of knowledge and attitude of heathcare workers about
ADRs.
8e10
The goal of this study was evaluation of clinical phar-
macists’ interventions in improvement of knowledge,
attitude and perception about ADRs in a referral
teaching hospital, Tehran, Iran.
METHOD
In this study, changes in knowledge, attitude (perspec-
tive towards ADR and way of saying and doing about
that) and perception (awareness or understanding of
the ADR) of healthcare workers of the Imam Khomeini
Complex Hospital (a tertiary referral hospital with 1200
beds that is afﬁliated to Tehran University of Medical
Sciences, Tehran, Iran) about ADRs were evaluated
before and after clinical pharmacists’ interventional
study. Based on WHO deﬁnition, ADR was considered as
any noxious, unintended and undesired effect of a drug
that occurs at doses used in humans for prophylaxis,
diagnosis or therapy. To assess knowledge, attitude and
perception of healthcare workers about ADR, a validate
questionnaire
1 was used. The questionnaire consisted of
a total of 15 questions (ﬁve questions for each of the
knowledge, attitude and perception). Multiple-choice
questions about ADR deﬁnition, goals and importance
of pharmacovigilance and types of drug-induced reac-
tions that must be reported were used for evaluation of
the participants’ knowledge. For evaluation of attitude
and perception, some cases with drug-induced ADRs
were designed and asked from the participants to
determine which of them must be reported.
In the ﬁrst phase of the study, the clinical pharmacists
(three persons) attended in different medical wards of
the hospital and invited from all healthcare workers
(medical students, nurses, physicians and pharmacist) to
participate in the study. From whom those had enough
time and were happy with our programme schedule
asked to ﬁll the questionnaire. Then, the participants
were invited to attend in an educational programme
(clinical pharmacists’ interventions) in the hospital.
Clinical pharmacists’ interventions included training
workshops (providing lectures and group discussion,
3 h/week for four consecutive weeks) and continuously
providing information at the hospital morning case
report section (every other day for 1 month) about ADR
importance, seriousness, preventability, necessity of
reporting and spontaneous reporting system and its
advantages. In the workshop, they learnt to ﬁll a yellow
card and emphasised on reporting any suspected reac-
tion regardless of uncertainty about the causality. After
3 months, the same questionnaire was ﬁlled again by the
participants in the educational programmes. Effects of
clinical pharmacists’ interventions in improvement of
knowledge, attitude and perception of the participants
about ADR were evaluated by comparing their responses
to the questions before and after interventions. All data
were analysed by Statistical Package for Social Sciences
(SPSS) software V.16.0. Results were reported as
frequency, and for comparing the before and after
intervention’s results, we used cross tabulation and c
2
test. Values <0.05 were considered as signiﬁcant.
RESULTS
From 136 healthcare workers that were positive for our
invitation, only 100 persons attended in the educational
programmes regularly and from them 82 questionnaires
Table 1 Reasons that cause ADR not be reported
Reason Before intervention After intervention p Value
Uncertain association between reaction and drug 18 (22) 17 (20.7) 1
Unimportant to report 13 (15.9) 11 (9) 0.30
Well known that do not need to be reported 21 (25.6) 16 (19.5) 0.23
Unaware of the existence of a national ADR reporting system 17 (20.7) 15 (18.3) 0.62
Did not know importance of reporting 12 (14.6) 10 (12.2) 0.69
Did not know how to report 20 (24.4) 12 (14.6) 0.02
Lack of time 11 (13.4) 16 (19.50) 0.18
Lack of ﬁnancial reimbursement 2 (2.4) 2 (2.4) 1
Fear of legal liability 2 (2.4) 2 (2.4) 1
Yellow card not available 16 (19.5) 9 (11) 0.04
Reporting system is too technical 18 (9.8) 14 (4.9) 0.12
Not enough information from the patient 82 (100) 3 (3.7) 0.0001
ADR, adverse drug reaction.
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ADR and KAP studywere ﬁlled out both before and after intervention with
same name. The questionnaires that were ﬁlled only in
one phases of the study were excluded. Thirty-ﬁve men
and 47 women including 7 (8.5%) physicians, 31
(37.8%) residents, 26 (31.7%) interns, 17 (20.7%)
nurses and 1 (1.2%) pharmacist participated in the
study. We had not any intention to invite senior or junior
of the wards and based on the demographic data of the
study we had participants from the both groups. Average
age of the participants was 30.9 years with SD of
6.7 years.
Fifty-one per cent (n¼42) of the healthcare workers
were aware of the IPC at Iranian ministry of health
before interventions and after that all the participants
knew this centre. Four people (4.9%) had attended in an
ADR workshop prior to this study. Sixty-nine (84.1%)
subjects had recognised at least one ADR before, and
following interventions, 73 (89%) cases have identiﬁed
ADR. Only seven (8.5%) people have reported ADR
before intervention that was increased signiﬁcantly to 18
(22%) by the interventions (p<0.001).
One of the question was designed to determine centre
that ADRs were reported previously by the participants.
Two (2.4%) responders had sent the ADR reports to the
IPC in Tehran, one (1.2%) to the Food and Drug
Organization in another city of Iran, one (1.2%) to the
manufacture and four (4.9%) to hospital’s ADR canter
before the interventions and after that reporting to the
IPC increased to 17 (20.7%) cases (p<0.001).
Doubt about occurrence of an ADR did not alter with
the interventions signiﬁcantly (63.4% vs 69.5%).
Reasons that caused the participants did not report ADR
are shown in table 1. The interventions had considerable
impact to reduce causes of under-reporting, including
did not know how to report (p¼0.002), yellow card not
available (p¼0.039) and lack of enough information
about the patient (p<0.0001).
All types of ADR that might promote healthcare
professionals for reporting them were improved signiﬁ-
cantly after clinical pharmacists’ interventions (table 2).
The next questions were about healthcare workers’
perception about ADR and spontaneous ADR reporting
goals. As it is indicated in table 3, our interventions had
a signiﬁcant effect on the participants’ total perception
about ADR spontaneous reporting.
Responders’ perception about spontaneous reporting
was not improved signiﬁcantly following the clinical
pharmacists’ interventions (table 4). Fifty-ﬁve (67.1%)
and 60 (73.2%) subjects believed that it is a professional
responsibility at pre- and post-interventional phases of
the study, respectively.
Regarding the participants’ attitude for reporting
ADRs, the question was, in which of the fallowing
conditions (carbamazepine-induced agranulocytosis,
hypoglycaemia following use of a new hypoglycaemic
agent, a new statin-induced myalgia, weight loss
following ﬂuoxetine therapy in a young women,
amoxicillin-induced skin rash, pedal oedema following
amlodipine therapy, bronchospasm following use of
new b blocker and a new antiepileptic-induced paraes-
thesia) you will ﬁll the yellow card? Only reporting of
serious reactions such as carbamazepine-induced
agranulocytosis was improved by clinical pharmacists’
interventions.
The participants’ preferred systems to report an ADR
have been indicated in table 5. Yellow card, online,
telephone and fax were frequently preferred methods
for ADRs reporting in this study, respectively (table 6).
Table 2 Reaction characteristics that might encourage healthcare professionals to report
Factor Before intervention After intervention p Value
A serious reaction 53 (64.6) 74 (90.2) <0.001
Unusual reaction 38 (46.3) 66 (80.5) <0.001
Reaction of a new product 36 (43.9) 46 (56.1) 0.02
Reaction not reported before for a particular drug 36 (43.9) 66 (80.5) <0.001
Reaction is well recognised for a particular drug 8 (9.8) 31 (37.8) <0.001
Any reaction (serious or non-serious, well known or new)
to an old or new product
7 (20.7) 26 (31.7) 0.004
Table 3 Healthcare workers’ perception about ADR and spontaneous reporting systems’ goals, before and after intervention
Goal Before intervention After intervention p Value
To enable safe drugs to be identiﬁed 36 (43.9) 46 (56.1) 0.02
To measure the incidence of ADR 39 (47.6) 57 (69.5) <0.001
To identify factors which might predispose to ADR 35 (42.7) 58 (70.7) <0.001
To identify previously unrecognised ADRs 56 (68.3) 70 (85.4) <0.001
To compare ADRs for drugs in similar therapeutic classes 36 (43.9) 52 (63.4) <0.001
To compare ADRs of same drug from different drug companies 44 (53.7) 44 (53.7) 1
ADRs, adverse drug reactions.
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ADR and KAP studyDISCUSSION
To the best of our knowledge, this is the ﬁrst survey in
Iran that have evaluated clinical pharmacists’ interven-
tions in improvement of the healthcare workers’
knowledge, attitudes and perceptions regarding ADR.
Our results showed that 91.5% of healthcare workers
of our hospital that participated in the study never
reported any ADR and 49% of them were not even aware
of the IPC at the ﬁrst phase of the study and obviously
improved after interventions. Iranian pharmacists are
more aware about the IPC
6 that may be related to
pharmacists’ more education about drugs’ safety.
Before the clinical pharmacists’ interventions, a little
(2.4%) of the responders sent ADR reports to the IPC at
the ministry of health and after that all the reports have
set to this centre. It shows that interventions improve
participant information regarding the centre that is
responsible for analysing and managing of their reports.
In previous research in Shiraz, Iran,
1 11% of the reports
were sent to the IPC.
The considerable numbers of healthcare workers in
the present study never reported an ADR that is
comparable with other studies.
4 61 1In the ﬁrst phase of
the study, the main reasons of under-reporting of ADR
were in order of had not enough information from the
patient, too well known to report, did not know how to
report, uncertain association and being unaware of the
existence of a national ADR reporting system.
Although there are many studies
12e18 that assess some
causes of under-reporting ADR, a little of them have
evaluated these barriers in hospitals. Results of a study
performed in a tertiary teaching hospital in Barcelona/
Spain are similar to our study, and lack of time to report
an ADR due to the workload of clinical practitioners was
detected as the most important reason to ADR under-
reporting. Other causes of under-reporting in that study
were lack of information about the spontaneous
reporting system, unavailability of yellow cards, doubt of
ADR causality assessment and lack of patient conﬁden-
tiality.
12 Other reasons for under-reporting of an ADR in
other studies were diagnosed as uncertain association,
too trivial to report, too well known to report, yellow
card unavailability, lack of time and not knowing how to
report.
13e18
In the present study, serious and unusual reactions,
unreported ADR before and reactions to a new product
were selected as more important ADR for reporting by
the participants. These are as the same as other studies’
results.
4 19e22 We found only one study in that the idea
of reporting all kind of ADRs was more often selected by
Table 4 Believes about spontaneous reporting, before and after intervention
Believes about spontaneous reporting Before intervention After intervention p Value
Professional responsibility 55 (67.1) 60 (73.2) 0.12
Felt that one report cannot modify the healthcare system 6 (7.3) 6 (7.3) 1
All serious ADRs were recognised before drug marketing 3 (3.7) 1 (1.2) 0.5
Completely aware of what should be reported 4 (4.9) 8 (9.8) 0.06
Yellow cards are too complicated 19 (23.2) 18 (22) 1
ADRs, adverse drug reactions.
Table 5 Healthcare workers’ attitude for reporting, some instances of adverse drug reaction
Event Category of reaction
Report before
the intervention
Report after the
intervention p Value
Carbamazepine-induced
agranulocytosis
Serious 30 (36.6) 74 (90.2) <0.001
Hypoglycaemia’s coma of a
new diabetes medication
Serious for a new drug 48 (58.5) 45 (54.9) 0.72
Myalgia with a new statin New drug 19 (23.2) 20 (14.2) 1
Weight loss after 8 weeks of
ﬂuoxetine
Well recognised for a
particular drug
69 (7.3) 13 (15.9) 0.14
Rash with amoxicillin after
6-day treatment
Well recognised for a
particular drug
18 (22) 12 (14.6) 0.33
Foot oedema after 4-month
amlodipine treatment
Well recognised for
a particular drug
19 (23.2) 18 (22) 1
Pain and tingling of tongue
after 2 weeks of a new
anti-seizure therapy
Reaction not reported
before for a particular
drug
33 (40.2) 40 (48.8) 0.34
Bronchospasm in an asthmatic
patient after the ﬁrst administration
of a b blocker
Serious well recognised
for a particular drug
33 (40.2) 29 (35.4) 0.63
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ADR and KAP studypharmacist than reporting only serious and unexpected
reactions.
23 After the study’s interventions, beliefs of
reporting of all drug-related reactions have been
increased signiﬁcantly.
Identifying previously unreported ADR was the most
important goal for ADR reporting in before and after the
interventions of the study. This was also reported by
other studies.
14 24 Regarding the inﬂuence of the clinical
pharmacists’ interventions on modifying healthcare
workers’ perception about ADR, just reporting carba-
mazepine-induced agranulocytosis showed a signiﬁcant
change, which indicated reporting of a serious reaction.
The preferred method to report an ADR was yellow
card followed by online report in both before and after
the interventions. In previous study in Iran, phone was
the selected method for ADR reporting by pharmacists.
1
Our study was a single-centre study with small sample
size and short duration between pre- and post-clinical
pharmacists’ interventions participants’ evaluation. It
seems that the consequence of the interventions will be
pale over time. Another limitation of our survey was
incompletely ﬁlled questionnaires that consequently we
could not enrol all 100 questionnaires for the analysis.
Educational programme including workshops, oral
presentations, group discussion, designing ADR news-
letters in hospitals, providing information about phar-
macovigilance for healthcare workers by mail, email,
verbal reminders, advertisement and continuous educa-
tion of nurses, physicians and pharmacists about ADRs,
regular attending of pharmacists in the medical wards
and involving actively in patient’s pharmaceutical care
are essential for improving healthcare workers knowl-
edge, attitudes and perceptions about ADRs.
7e10
In conclusion, clinical pharmacists’ interventions can
improve knowledge, attitude and perception of health-
care workers about ADR that is a great issue of impor-
tance regarding pharmacovigilance and public health.
Funding This study was supported by a grant from Ofﬁce of Vice-Chancellor
for Research of Tehran University of Medical Sciences.
Competing interests None.
Contributors HK and SD-K: clinical pharmacists of the hospital and provided
educational programmes for the participants of the study and revised the
manuscript. NM: data gathering and manuscript preparation. NH: data
gathering and provided educational programme for the participants of the
study. A-AK: study design and statistical analysis.
Provenance and peer review Not commissioned; externally peer reviewed.
REFERENCES
1. Vessal G, Mardani Z, Mollai M. Knowledge, attitudes, and perceptions
of pharmacists to ADR reporting in Iran. Pharm World Sci
2009;31:183e7.
2. Lazarou J, Pomeranz BH, Corey PN. Incidence of ADR in hospitalized
patients: a meta-analysis of prospective studies. JAMA
1998;279:1200e5.
3. Millar JS. Consultation owing to ADR in a single perception. Br J Gen
Pract 2001;51:130e1.
4. Figueiras A, Tato F, Fontain ˜as J, et al. Physicians’ attitudes towards
voluntary reporting of adverse drug events. J Eval Clin Pract
2001;7:347e54.
5. Rawlins MD. Pharmacovigilance: paradise lost, regained or
postponed? The William Withering Lecture 1994. J R Coll Physicians
Lond 1995;29:41e9.
6. Vallano A, Cereza G, Pedro `sC ,et al. Obstacles and solutions for
spontaneous reporting of ADRs in the hospital. Br J Clin Pharmacol
2005;60:653e8.
7. Salehifar E, Ala SH, Gholami KH. Knowledge, attitudes, and
perceptions of pharmacists and Nurses ADR reporting in
Mazandaran, Iran. Mazandaran University of Medical Science Journal
2007;56:115e25.
8. Fincham JA. Statewide program to stimulate reporting of adverse
drug reactions. J Pharm Pract 1989;2:239e44.
9. McGettigan P, Golden J, Conroy RM, et al. Reporting of adverse drug
reactions by hospital doctors and the response to intervention. Br J
Clin Pharmacol 1997;44:98e100.
10. Nazario M, Feliu JF, Rivera GC. Adverse drug reactions: the San
Juan Department of Veterans Affairs Medical Center experience.
Hosp Pharm 1994;244:249e50.
11. Cosentino M, Leoni O, Oria C, et al. Hospital-based survey of doctors’
attitudes to ADRs and perception of drug-related risk for adverse
reaction occurrence. Pharmacoepidemiol Drug Saf 1999;8(Suppl 1):
S27e35.
12. Evans SM, Berry JG, Smith BJ, et al. Attitudes and barriers to incident
reporting: a collaborative hospital study. Qual Saf Health Care
2006;15:39e43.
13. Bateman DN, Sanders GL, Rawlins MD. Attitudes to ADR reporting in
the Northern Region. Br J Clin Pharmacol 1992;34:421e6.
14. Belton KJ, Lewis SC, Payne S, et al. Attitudinal survey of ADR
reporting by medical practitioners in the United Kingdom. Br J Clin
Pharmacol 1995;39:223e6.
15. Eland IA, Belton KJ, van Grootheest AC, et al. Attitudinal survey
of voluntary reporting of ADR. Br J Clin Pharmacol 1999;48:
623e7.
16. Ba ¨ckstro ¨m M, Mjorndal T, Dahlqvist R, et al. Attitudes to reporting
ADR in northern Sweden. Eur J Clin Pharmacol 2000;56:729e32.
17. McGettigan P, Feely J. ADR reporting: opinions and attitudes of
medical practitioners in Ireland. Pharmacoepidemiol Drug Saf
1995;4:355e8.
18. Belton KJ. Attitude survey of adverse drug-reaction reporting by
health care professionals across the European Union. The European
Pharmacovigilance Research Group. Eur J Clin Pharmacol
1997;52:423e7.
19. Green CF, Mottram DR, Rowe PH, et al. Attitudes and knowledge of
hospital pharmacists to ADR reporting. Br J Clin Pharmacol
2001;51:81e6.
20. Lee KK, Chan TY, Raymond K, et al. Pharmacists’ attitudes toward
ADRs reporting in Hong Kong. Ann Pharmacother 1994;28:1400e3.
21. Sweis D, Wong IC. A survey on factors that could affect ADR
reporting according to hospital pharmacists in Great Britain. Drug Saf
2000;23:165e72.
22. Generali JA, Danish MA, Rosenbaum SE. Knowledge of and attitudes
about ADR reporting among Rhode Island pharmacists. Ann
Pharmacother 1995;29:365e9.
23. Zerrin Toklu H, Uysal MK. The knowledge and attitude of the Turkish
community pharmacists toward pharmacovigilance in the Kadikoy
district of Istanbul. Pharm World Sci 2008;30:556e62.
24. Cosentino M, Leoni O, Banﬁ F, et al. Attitudes to ADR reporting by
medical practitioners in a northern Italian district. Pharmacol Res
1997;35:85e8.
Table 6 Healthcare workers’ preferred method for
reporting of adverse drug reaction
Preferred
method
Before
intervention
After
intervention p Value
Yellow card 29 (32) 34 (45.1) 0.09
Telephone 18 (24.3) 16 (21.6) 0.21
Fax 1 (1.4) 0 0.33
Online 21 (28.4) 23 (31.1) 0.45
None 5 (6.8) 1 (1.4) 0.02
Khalili H, Mohebbi N, Hendoiee N, et al. BMJ Open 2012;2:e000367. doi:10.1136/bmjopen-2011-000367 5
ADR and KAP study